SBI Securities’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28K Buy
2,532
+1,420
+128% +$8.69K ﹤0.01% 1417
2026
Q1
$8.51K Buy
1,112
+99
+10% +$757 ﹤0.01% 1797
2025
Q4
$9.85K Buy
1,013
+1,001
+8,342% +$8.51K ﹤0.01% 1727
2025
Q3
$50 Buy
12
+1
+9% +$6 ﹤0.01% 3714
2025
Q2
$102 Hold
11
﹤0.01% 3532
2025
Q1
$107 Hold
11
﹤0.01% 3419
2024
Q4
$133 Buy
+11
New +$134 ﹤0.01% 3376

Other funds holding REPL

SBI Securities's REPL Position: Q2 2026 in Review

SBI Securities increased its Replimune Group (REPL) stake by 128% in Q2 2026, buying an estimated $8.69K and bringing the position to 2,532 shares worth $28K. The position accounts for ﹤0.01% of the portfolio, ranked #1417.

SBI Securities first reported a position in REPL in Q4 2024 and has held it in 7 quarters since. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • SBI Securities held 2,532 shares of Replimune Group worth $28K as of Q2 2026.
  • SBI Securities bought 1,420 Replimune Group shares in Q2 2026, an estimated $8.69K.
  • Replimune Group made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1417 holding.
  • SBI Securities first reported a position in Replimune Group in Q4 2024 and has held it in 7 quarters since.
  • 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.